Efficacy and safety of daclatasvir plus pegylated-interferon alfa 2a and ribavirin in previously untreated HCV subjects coinfected with HIV and HCV genotype-1: a Phase III, open-label study
- Sulkowski, M.S.
- Fessel, W.J.
- Lazzarin, A.
- Berenguer, J.
- Zakharova, N.
- Cheinquer, H.
- Côté, P.
- Dieterich, D.
- Gadano, A.
- Matthews, G.
- Molina, J.-M.
- Moreno, C.
- Pineda, J.A.
- Pulido, F.
- Rivero, A.
- Rockstroh, J.
- Hernandez, D.
- McPhee, F.
- Eley, T.
- Liu, Z.
- Mendez, P.
- Hughes, E.
- Noviello, S.
- Ackerman, P.
ISSN: 1936-0541, 1936-0533
Datum der Publikation: 2017
Ausgabe: 11
Nummer: 2
Seiten: 188-198
Art: Artikel